HIGH

Zydus Pharmaceuticals Recalls Chlorpromazine Hydrochloride Tablets Due to Contamination

Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 100-count bottles of 50 mg tablets due to excessive levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact health providers for guidance.

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brands
Zydus Pharmaceuticals (USA) Inc., CHLORPROMAZINE HYDROCHLORIDE
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A

Product Details

The recalled product is Chlorpromazine Hydrochloride Tablets, USP, available in 50 mg dosage. They are packaged in 100-count bottles. The lot numbers include Z306327, Z306748, Z401154, Z403738, and Z405645.

The Hazard

The recall stems from CGMP deviations, specifically the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable intake limits. This contamination could pose serious health risks to consumers.

Reported Incidents

There are no specific reports of injuries or deaths related to this recall. The contamination is classified as a Class II risk due to potential health impacts.

What to Do

Consumers should stop using Chlorpromazine Hydrochloride Tablets immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for further assistance.

Contact Information

For more information, consumers can visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0634-2025.

Key Facts

  • Recall date: September 3, 2025
  • Distribution: Nationwide in the USA
  • Hazard classification: Class II
  • Stop using the product immediately
  • Contact healthcare providers for guidance

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeChlorpromazine Hydrochloride Tablets
Sold At
Multiple Retailers

Product Details

Model Numbers
Z306327
Z306748
Z401154
Z403738
Z405645
UPC Codes
70710-1129
70710-1130
70710-1131
+12 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more